Literature DB >> 12120479

The history and threat of biological warfare and terrorism.

Donald L Noah1, Kermit D Huebner, Robert G Darling, Joseph F Waeckerle.   

Abstract

The inevitable conclusion is that the availability of biological warfare agents and supporting technologic infrastructure, coupled with the fact that there are many people motivated to do harm to the United States, means that America must be prepared to defend her homeland against biological agents. Some have argued to the contrary, that the threat and risks from a biological weapon attack are not to be considered serious, because [39]: They've not been used yet on a large scale so they probably won't be in the near future. Their use is so morally repugnant that they probably won't be used at all. The technologic hurdles associated with isolating, growing, purifying, weaponizing, and disseminating adequate quantities of pathologic agents are so high that only the most advanced laboratories could attempt the process. Similar to a 'nuclear winter,' the aftermath of a biological attack is so unthinkable that none would attempt it. Unfortunately, the trends associated with biotechnology globalization, terrorist group dynamics, and global/regional politics render these beliefs untenable and inappropriate, as recent events have underscored. To that end, the United States has accelerated its program of defense against biological weapons, as it must. Biological weapons are such dreadful weapons of uniqueness and complexity that a specific defense strategy is paramount. Elements of this program include pharmaceutical stockpiles, heightened surveillance systems, energized vaccine development programs, and comprehensive training initiatives. Although the depth and breadth of these efforts are unprecedented, above all these efforts is the absolute necessity for medical and public health care professionals to be educated and actively involved. These professionals are the sine qua non of future defensive readiness. This is just the start; unfortunately, there is no end yet in sight.

Entities:  

Mesh:

Year:  2002        PMID: 12120479     DOI: 10.1016/s0733-8627(01)00002-5

Source DB:  PubMed          Journal:  Emerg Med Clin North Am        ISSN: 0733-8627            Impact factor:   2.264


  7 in total

Review 1.  Bioshock: Biotechnology and Bioterrorism.

Authors:  N Moorchung; A K Sharma; S R Mehta
Journal:  Med J Armed Forces India       Date:  2011-07-21

2.  Zoonoses likely to be used in bioterrorism.

Authors:  C Patrick Ryan
Journal:  Public Health Rep       Date:  2008 May-Jun       Impact factor: 2.792

Review 3.  Biodefence research two decades on: worth the investment?

Authors:  Carrie M Long; Andrea Marzi
Journal:  Lancet Infect Dis       Date:  2021-08       Impact factor: 71.421

Review 4.  Biowarfare, bioterrorism and biocrime: A historical overview on microbial harmful applications.

Authors:  Manuela Oliveira; Gabriella Mason-Buck; David Ballard; Wojciech Branicki; António Amorim
Journal:  Forensic Sci Int       Date:  2020-06-20       Impact factor: 2.395

Review 5.  Biowarfare and bioterrorism.

Authors:  Michael D Christian
Journal:  Crit Care Clin       Date:  2013-07       Impact factor: 3.598

6.  Unusual Presentations of Abdominal Melioidosis.

Authors:  Vignesh Kumar Mohan; Komalavalli Rajesh; Sripriya Srinivas; R Ravi; Jimmy Prabhakaran; K Srinivasan; Subha Sundaramoorthy
Journal:  J Glob Infect Dis       Date:  2021-01-29

Review 7.  Bioterrorism and children: unique concerns with infection control and vaccination.

Authors:  Kay B Leissner; Robert S Holzman; Mary Ellen McCann
Journal:  Anesthesiol Clin North Am       Date:  2004-09
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.